GO
Loading...

U.S. News

More

Contact U.S. News

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    › Learn More

Don't Miss

U.S. Video

  • Kite Pharma is working on a treatment which involves taking a cancer patient's own t-cells out of their body, genetically modifying them to better target cancer, and then re-administering them. Its CEO Arie Belldegrun, provides insight to the positive study with the therapy.

  • After news Burger King is buying Tim Hortons, the "Street Signs" crew ask one of Burger King's franchisees Gavin O'Neill, how this could impact business.

  • McDonald's needs growth. Doug McIntyre, 24/7 Wall Street editor thinks it's feasible the company could buy Chipotle back.